1. ASCO 2013: from the rediscovery of old recipes to targeted oncology

   • Jean-François Morère

   Editorial 23 August 2013 Pages: 157 - 158

2. Lung cancer-initiating cells: a novel target for cancer therapy

   • Brian J. Morrison
   • John C. Morris
   • Jason C. Steel

   Review Open access 15 January 2013 Pages: 159 - 172

   

3. The predictive role of skin rash with cetuximab and panitumumab in colorectal cancer patients: a systematic review and meta-analysis of published trials

   • F. Petrelli
   • K. Borgonovo
   • S. Barni

   Review 16 January 2013 Pages: 173 - 181

   

4. Bevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutation

   • Filip Janku
   • Jennifer J. Wheler
   • Razelle Kurzrock

   Original Research 12 February 2013 Pages: 183 - 188

   

5. Is 1,25-dihydroxyvitamin D₃ receptor expression a potential Achilles’ heel of CD44+ oral squamous cell carcinoma cells?

   • Martin Grimm
   • Dorothea Alexander
   • Siegmar Reinert

   Original Research 15 January 2013 Pages: 189 - 201

   

6. The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients

   • Mhd Y. Al-Marrawi
   • Brian I. Rini
   • For the International mRCC Database Consortium

   Original Research 09 January 2013 Pages: 203 - 209

   

7. Clinical activity of sunitinib in patients with advanced desmoplastic round cell tumor: a case series

   • Antoine Italiano
   • Michèle Kind
   • Binh Bui

   Day-to-Day Practice 06 January 2013 Pages: 211 - 213